Stocks · News reference
Greenland Mines Outlines $2B Valuation for Sarfartoq Project
Greenland Mines released an Initial Assessment for its Sarfartoq project, projecting a pre-tax net present value up to $2.05 billion.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 25, 2026, 2:22 PM
- Checked
- Aug 25, 2026, 2:22 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Dow Falls Over 150 Points; JM Smucker Shares Gain Following Upbeat Q1 Earnings
Dow Jones fell 150 points, NASDAQ declined 0.27%, and S&P 500 dropped 0.07%. Industrials shares jumped 1% while consumer discretionary stocks fell 0.7%. J.M. Smucker Co reported better-than-expected earnings and raised FY27 guidance. Equities mostly up in Asia and Europe.
Read original at benzingaUS Stocks Mostly Flat; Fed's Preferred Inflation Gauge Rises By 3.7% In July
US stocks mixed, with S&P 500 up 0.1%. Industrials jumped 1.1%, health care fell 0.8%. PCE price index up 3.7%, GDP up 1.5%, personal income up 0.4%.
Read original at benzingaGreenland Mines Prices Its $20M Public Offering Of 4M Shares
Read original at benzingaNeoGenomics shares are trading higher after the company announced that its RaDaR ST molecular residual disease assay has received expanded coverage from the Centers for Medicare & Medicaid Services' Molecular Diagnostic Services Program.
Read original at benzingaNeoGenomics’ RaDaR ST Molecular Residual Disease Assay Receives Expanded Coverage From CMS’ MolDX To Include Immunotherapy Monitoring For Patients With Late-Stage Solid Tumors
New coverage extends RaDaR ST to patients with advanced cancer on immunotherapy, expanding MRD testing across the cancer care continuumNeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions
Read original at benzinga